Innate Immunity and Protective Neuroinflammation: New Emphasis on the Role of Neuroimmune Regulatory Proteins

International Review of Neurobiology

Volumn 82, Issue , 2007, Pages 29-55

  Griffiths, M ^a   Neal, J W ^a   Gasque, P ^a,b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b GRII   (Reunion)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BLOOD BRAIN BARRIER; BRAIN; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; NERVOUS SYSTEM; PATHOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; HUMANS; IMMUNITY, NATURAL; INFLAMMATION; NERVOUS SYSTEM; NEUROIMMUNOMODULATION;

EID: 34547519410     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(07)82002-2     Document Type: Review

References (162)

1. Abeyama K., Stern D.M., Ito Y., Kawahara K., Yoshimoto Y., Tanaka M., Uchimura T., Ida N., Yamazaki Y., Yamada S., Yamamoto Y., Yamamoto H., et al. The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. J. Clin. Invest. 115 (2005) 1267-1274
2. Agoropoulou C., Wing M.G., and Wood A. CD59 expression and complement susceptibility of human neuronal cell line (NTera2). Neuroreport 7 (1996) 997-1004
3. Angata T., Kerr S.C., Greaves D.R., Varki N.M., Crocker P.R., and Varki A. Cloning and characterization of human Siglec-11. A recently evolved signaling that can interact with SHP-1 and SHP-2 and is expressed by tissue macrophages, including brain microglia. J. Biol. Chem. 277 (2002) 24466-24474
4. Bamberger M.E., Harris M.E., McDonald D.R., Husemann J., and Landreth G.E. A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation. J. Neurosci. 23 (2003) 2665-2674
5. Barclay A.N., Wright G.J., Brooke G., and Brown M.H. CD200 and membrane protein E interactions in the control of myeloid cells. Trends Immunol. 23 (2002) 285-290
6. Barnum S.R., Ames R.S., Maycox P.R., Hadingham S.J., Meakin J., Harrison D., and Parsons A.A. Expression of the complement C3a and C5a receptors after permanent focal ischemia: An alternative interpretation. Glia 38 (2002) 169-173
7. Baron R., Harpaz I., Nemirovsky A., Cohen H., and Monsonego A. Immunity and neuronal repair in the progression of Alzheimer's disease: A brief overview. Exp. Gerontol. 42 (2007) 64-69
8. Bergman P., Johansson L., Wan H., Jones A., Gallo R.L., Gudmundsson G.H., Hokfelt T., Jonsson A.B., and Agerberth B. Induction of the antimicrobial peptide CRAMP in the blood-brain barrier and meninges after meningococcal infection. Infect. Immun. 74 (2006) 6982-6991
9. Bilak M.M., Becerra S.P., Vincent A.M., Moss B.H., Aymerich M.S., and Kuncl R.W. Identification of the neuroprotective molecular region of pigment epithelium-derived factor and its binding sites on motor neurons. J. Neurosci. 22 (2002) 9378-9386
10. Boos L., Szalai A.J., and Barnum S.R. C3a expressed in the central nervous system protects against LPS-induced shock. Neurosci. Lett. 387 (2005) 68-71
11. Broderick C., Hoek R.M., Forrester J.V., Liversidge J., Sedgwick J.D., and Dick A.D. Constitutive retinal CD200 expression regulates resident microglia and activation state of inflammatory cells during experimental autoimmune uveoretinitis. Am. J. Pathol. 161 (2002) 1669-1677
12. Brown E.J., and Frazier W.A. Integrin-associated protein (CD47) and its ligands. Trends Cell Biol. 11 (2001) 130-135
13. Bsibsi M., Ravid R., Gveric D., and van Noort J.M. Broad expression of Toll-like receptors in the human central nervous system. J. Neuropathol. Exp. Neurol. 61 (2002) 1013-1021
14. Bsibsi M., Persoon-Deen C., Verwer R.W., Meeuwsen S., Ravid R., and Van Noort J.M. Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators. Glia 53 (2006) 688-695
15. Buisson A., Nicole O., Docagne F., Sartelet H., Mackenzie E.T., and Vivien D. Up-regulation of a serine protease inhibitor in astrocytes mediates the neuroprotective activity of transforming growth factor beta1. FASEB J. 12 (1998) 1683-1691
16. Buisson A., Lesne S., Docagne F., Ali C., Nicole O., MacKenzie E.T., and Vivien D. Transforming growth factor-beta and ischemic brain injury. Cell. Mol. Neurobiol. 23 (2003) 539-550
17. Burudi E.M., Riese S., Stahl P.D., and Regnier-Vigouroux A. Identification and functional characterisation of the mannose receptor in astrocytes. Glia 25 (1999) 44-55
18. Butovsky O., Koronyo-Hamaoui M., Kunis G., Ophir E., Landa G., Cohen H., and Schwartz M. Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc. Natl. Acad. Sci. USA 103 (2006) 11784-11789
19. Cameron C.M., Barrett J.W., Mann M., Lucas A., and McFadden G. Myxoma virus M128L is expressed as a cell surface CD47-like virulence factor that contributes to the downregulation of macrophage activation in vivo. Virology 337 (2005) 55-67
20. Canova C., Neal J.W., and Gasque P. Expression of innate immune complement regulators on brain epithelial cells during human bacterial meningitis. J. Neuroinflammation 3 (2006) 22
21. Cavanaugh K.P., Gurwitz D., Cunningham D.D., and Bradshaw R.A. Reciprocal modulation of astrocyte stellation by thrombin and protease nexin-1. J. Neurochem. 54 (1990) 1735-1743
22. Cerwenka A., and Lanier L.L. Natural killer cells, viruses and cancer. Nat. Rev. Immunol. 1 (2001) 41-49
23. Citron B.A., Smirnova I.V., Arnold P.M., and Festoff B.W. Upregulation of neurotoxic serine proteases, prothrombin, and protease-activated receptor 1 early after spinal cord injury. J. Neurotrauma 17 (2000) 1191-1203
24. Compston D.A., Morgan B.P., Campbell A.K., Wilkins P., Cole G., Thomas N.D., and Jasani B. Immunocytochemical localization of the terminal complement complex in multiple sclerosis. Neuropathol. Appl. Neurobiol. 15 (1989) 307-316
25. Crocker P.R. Siglecs in innate immunity. Curr. Opin. Pharmacol. 5 4 (2005) 431-437
26. Dalpke A.H., Schafer M.K., Frey M., Zimmermann S., Tebbe J., Weihe E., and Heeg K. Immunostimulatory CpG-DNA activates murine microglia. J. Immunol. 168 (2002) 4854-4863
27. De Simone R., Ajmone-Cat M.A., and Minghetti L. Atypical antiinflammatory activation of microglia induced by apoptotic neurons: Possible role of phosphatidylserine-phosphatidylserine receptor interaction. Mol. Neurobiol. 29 (2004) 197-212
28. De Simoni M.G., Rossi E., Storini C., Pizzimenti S., Echart C., and Bergamaschini L. The powerful neuroprotective action of C1-inhibitor on brain ischemia-reperfusion injury does not require C1q. Am. J. Pathol. 164 (2004) 1857-1863
29. de Vries H.E., Hendriks J.J., Honing H., De Lavalette C.R., van der Pol S.M., Hooijberg E., Dijkstra C.D., and van den Berg T.K. Signal-regulatory protein alpha-CD47 interactions are required for the transmigration of monocytes across cerebral endothelium. J. Immunol. 168 (2002) 5832-5839
30. Delhaye S., Paul S., Blakqori G., Minet M., Weber F., Staeheli P., and Michiels T. Neurons produce type I interferon during viral encephalitis. Proc. Natl. Acad. Sci. USA 103 (2006) 7835-7840
31. Dihanich M., Kaser M., Reinhard E., Cunningham D., and Monard D. Prothrombin mRNA is expressed by cells of the nervous system. Neuron 6 (1991) 575-581
32. Docagne F., Nicole O., Marti H.H., MacKenzie E.T., Buisson A., and Vivien D. Transforming growth factor-beta1 as a regulator of the serpins/t-PA axis in cerebral ischemia. FASEB J. 13 (1999) 1315-1324
33. Dowling P., Shang G., Raval S., Menonna J., Cook S., and Husar W. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J. Exp. Med. 184 (1996) 1513-1518
34. Ehlers M.R. CR3: A general purpose adhesion-recognition receptor essential for innate immunity. Microbes Infect. 2 (2000) 289-294
35. Eikelenboom P., Bate C., Van Gool W.A., Hoozemans J.J., Rozemuller J.M., Veerhuis R., and Williams A. Neuroinflammation in Alzheimer's disease and prion disease. Glia 40 (2002) 232-239
36. El Khoury J.B., Moore K.J., Means T.K., Leung J., Terada K., Toft M., Freeman M.W., and Luster A.D. CD36 mediates the innate host response to beta-amyloid. J. Exp. Med. 197 (2003) 1657-1666
37. Elward K., and Gasque P. "Eat me" and "don't eat me" signals govern the innate immune response and tissue repair in the CNS: Emphasis on the critical role of the complement system. Mol. Immunol. 40 (2003) 85-94
38. Elward K., Griffiths M., Mizuno M., Harris C.L., Neal J.W., Morgan B.P., and Gasque P. CD46 plays a key role in tailoring innate immune recognition of apoptotic and necrotic cells. J. Biol. Chem. 280 (2005) 36342-36354
39. Esen N., Tanga F.Y., DeLeo J.A., and Kielian T. Toll-like receptor 2 (TLR2) mediates astrocyte activation in response to the Gram-positive bacterium Staphylococcus aureus. J. Neurochem. 88 (2004) 746-758
40. Eugster H.P., Frei K., Bachmann R., Bluethmann H., Lassmann H., and Fontana A. Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1. Eur. J. Immunol. 29 (1999) 626-632
41. Everett H., and McFadden G. Apoptosis: An innate immune response to virus infection. Trends Microbiol. 7 (1999) 160-165
42. Fadok V.A., Warner M., Bratton D.L., and Henson P.M. CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor ( v beta 3). J. Immunol. 161 (1998) 6350-6357
43. Fadok V.A., Bratton D.L., Rose D.M., Pearson A., Ezekewitz A.B., and Henson P.M. A receptor for phosphatidylserine specific clearance of apoptotic cells. Nature 405 (2000) 85-90
44. Fassbender K., Walter S., Kuhl S., Landmann R., Ishii K., Bertsch T., Stalder A.K., Muehlhauser F., Liu Y., Ulmer A.J., Rivest S., Lentschat A., et al. The LPS receptor (CD14) links innate immunity with Alzheimer's disease. FASEB J. 18 (2004) 203-205
45. Fillon S., Soulis K., Rajasekaran S., Benedict-Hamilton H., Radin J.N., Orihuela C.J., El Kasmi K.C., Murti G., Kaushal D., Gaber M.W., Weber J.R., Murray P.J., et al. Platelet-activating factor receptor and innate immunity: Uptake of gram-positive bacterial cell wall into host cells and cell-specific pathophysiology. J. Immunol. 177 (2006) 6182-6191
46. Fischer W.H., and Hugli T.E. Regulation of B cell functions by C3a and C3a(desArg): Suppression of TNF-alpha, IL-6, and the polyclonal immune response. J. Immunol. 159 (1997) 4279-4286
47. Flugel A., Schwaiger F.W., Neumann H., Medana I., Willem M., Wekerle H., Kreutzberg G.W., and Graeber M.B. Neuronal FasL induces cell death of encephalitogenic T lymphocytes. Brain Pathol. 10 (2000) 353-364
48. Foell D., Wittkowski H., Vogl T., and Roth J. S100 proteins expressed in phagocytes: A novel group of damage-associated molecular pattern molecules. J. Leukoc. Biol. 81 (2007) 28-37
49. Foster-Cuevas M., Wright G.J., Puklavec M.J., Brown M.H., and Barclay A.N. Human herpesvirus 8 K14 protein mimics CD200 in down-regulating macrophage activation through CD200 receptor. J. Virol. 78 (2004) 7667-7676
50. Francis K., Lewis B.M., Akatsu H., Monk P.N., Cain S.A., Scanlon M.F., Morgan B.P., Ham J., and Gasque P. Complement C3a receptors in the pituitary gland: A novel pathway by which an innate immune molecule releases hormones involved in the control of inflammation. FASEB J. 17 (2003) 2266-2268
51. Gabriel C., Ali C., Lesne S., Fernandez-Monreal M., Docagne F., Plawinski L., MacKenzie E.T., Buisson A., and Vivien D. Transforming growth factor alpha-induced expression of type 1 plasminogen activator inhibitor in astrocytes rescues neurons from excitotoxicity. FASEB J. 17 (2003) 277-279
52. Gardai S.J., McPhillips K.A., Frasch S.C., Janssen W.J., Starefeldt A., Murphy-Ullrich J.E., Bratton D.L., Oldenborg P.A., Michalak M., and Henson P.M. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 123 (2005) 321-334
53. Gasque P. Complement: A unique innate immune sensor for danger signals. Mol. Immunol. 41 (2004) 1089-1098
54. Gasque P., Fontaine M., and Morgan B.P. Complement expression in human brain. Biosynthesis of terminal pathway components and regulators in human glial cells and cell lines. J. Immunol. 154 (1995) 4726-4733
55. Gasque P., Singhrao S.K., Neal J.W., Gotze O., and Morgan B.P. Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflammed human central nervous system. Am. J. Pathol. 150 (1996) 2-11
56. Gasque P., Jones J., Singhrao S.K., and Morgan B.P. Identification of an astrocyte cell population from human brain that expresses perforin, a cytotoxic protein implicated in immune defense. J. Exp. Med. 187 (1998) 451-460
57. Gasque P., Dean Y.D., McGreal E.P., VanBeek J., and Morgan B.P. Complement components of the innate immune system in health and disease in the CNS. Immunopharmacology 49 (2000) 171-186
58. Gendelman H.E. Neural immunity: Friend or foe?. J. Neurovirol. 8 (2002) 474-479
59. Gingrich M.B., and Traynelis S.F. Serine proteases and brain damage-is there a link?. Trends Neurosci. 23 (2000) 399-407
60. Glezer I., Lapointe A., and Rivest S. Innate immunity triggers oligodendrocyte progenitor reactivity and confines damages to brain injuries. FASEB J. 20 (2006) 750-752
61. Gordon D.L., Sadlon T.A., Wesselingh S.L., Russell S.M., Johnstone R.W., and Purcell D.F. Human astrocytes express membrane cofactor protein (CD46), a regulator of complement activation. J. Neuroimmunol. 36 (1992) 199-208
62. Gordon S. Pattern recognition receptors: Doubling up for the innate immune response. Cell 111 (2002) 927-930
63. Grand R.J., Turnell A.S., and Grabham P.W. Cellular consequences of thrombin-receptor activation. Biochem. J. 313 Pt. 2 (1996) 353-368
64. Gregory C.D. CD14 dependent clearance of apoptotic cells: Relevance to the immune system. Curr. Opin. Immunol. 12 (2000) 27-34
65. Gregory C.D., and Devitt A. The macrophage and the apoptotic cell: An innate immune interaction viewed simplistically?. Immunology 113 (2004) 1-14
66. Grimsley C., and Ravichandran K.S. Cues for apoptotic cell engulfment: Eat-me, don't eat-me and come-get-me signals. Trends Cell Biol. 13 (2003) 648-656
67. Hamann J., Vogel B., van Schijndel G.M., and van Lier R.A. The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF). J. Exp. Med. 184 (1996) 1185-1189
68. Hanayama R., Tanaka M., Miwa K., Shinohara A., Iwamatsu A., and Nagata S. Identification of a factor that links apoptotic cells to phagocytes. Nature 417 (2002) 182-187
69. Hao H.N., Zhao J., Lotoczky G., Grever W.E., and Lyman W.D. Induction of human beta-defensin-2 expression in human astrocytes by lipopolysaccharide and cytokines. J. Neurochem. 77 (2001) 1027-1035
70. Hauwel M., Furon E., Canova C., Griffiths M., Neal J., and Gasque P. Innate (inherent) control of brain infection, brain inflammation and brain repair: The role of microglia, astrocytes, "protective" glial stem cells and stromal ependymal cells. Brain Res. Brain Res. Rev. 48 (2005) 220-233
71. Helmy K.Y., Katschke Jr. K.J., Gorgani N.N., Kljavin N.M., Elliott J.M., Diehl L., Scales S.J., Ghilardi N., and van Lookeren Campagne M. CRIg: A macrophage complement receptor required for phagocytosis of circulating pathogens. Cell 124 (2006) 915-927
72. Hoek R.M., Ruuls S.R., Murphy C.A., Wright G.J., Goddard R., Zurawski S.M., Blom B., Homola M.E., Streit W.J., Brown M.H., Barclay A.N., and Sedgwick J.D. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 290 (2000) 1768
73. Husemann J., Loike J.D., Anankov R., Febbraio M., and Silverstein S.C. Scavenger receptors in neurobiology and neuropathology: Their role on microglia and other cells of the nervous system. Glia 40 (2002) 195-205
74. Jiang H., Burdick D., Glabe C.G., Cotman C.W., and Tenner A.J. beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain. J. Immunol. 152 (1994) 5050-5059
75. Jones C., Virji M., and Crocker P.R. Recognition of sialylated meningococcal lipopolysaccharide by siglecs expressed on myeloid cells leads to enhanced bacterial uptake. Mol. Microbiol. 49 (2003) 1213-1225
76. Kielian T., Mayes P., and Kielian M. Characterization of microglial responses to Staphylococcus aureus: Effects on cytokine, costimulatory molecule, and Toll-like receptor expression. J. Neuroimmunol. 130 (2002) 86-99
77. Korb L.C., and Ahearn J.M. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: Complement deficiency and systemic lupus erythematosus revisited. J. Immunol. 158 (1997) 4525-4528
78. Kovacs G.G., Gasque P., Strobel T., Lindeck-Pozza E., Strohschneider M., Ironside J.W., Budka H., and Guentchev M. Complement activation in human prion disease. Neurobiol. Dis. 15 (2004) 21-28
79. Laflamme N., and Rivest S. Toll-like receptor 4: The missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components. FASEB J. 15 (2001) 155-163
80. Laflamme N., Echchannaoui H., Landmann R., and Rivest S. Cooperation between toll-like receptor 2 and 4 in the brain of mice challenged with cell wall components derived from gram-negative and gram-positive bacteria. Eur. J. Immunol. 33 (2003) 1127-1138
81. Lazarov-Spiegler O., Solomon A.S., Zeev-Brann A.B., Hirschberg D.L., Lavie V., and Schwartz M. Transplantation of activated macrophages overcomes central nervous system regrowth failure. FASEB J. 10 (1996) 1296-1302
82. Lee K.R., Colon G.P., Betz A.L., Keep R.F., Kim S., and Hoff J.T. Edema from intracerebral hemorrhage: The role of thrombin. J. Neurosurg. 84 (1996) 91-96
83. Lehnardt S., Massillon L., Follett P., Jensen F.E., Ratan R., Rosenberg P.A., Volpe J.J., and Vartanian T. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc. Natl. Acad. Sci. USA 100 (2003) 8514-8519
84. Leonardi-Essmann F., Emig M., Kitamura Y., Spanagel R., and Gebicke-Haerter P.J. Fractalkine-upregulated milk-fat globule EGF factor-8 protein in cultured rat microglia. J. Neuroimmunol. 160 (2005) 92-101
85. Li M.O., Sarkisian M.R., Mehal W.Z., Rakic P., and Flavell R.A. Phosphatidylserine receptor is required for clearance of apoptotic cells. Science 302 (2003) 1560-1563
86. Linehan S.A., Martinez-Pomares L., Stahl P.D., and Gordon S. Mannose receptor and its putative ligands in normal murine lymphoid and nonlymphoid organs: In situ expression of mannose receptor by selected macrophages, endothelial cells, perivascular microglia, and mesangial cells, but not dendritic cells. J. Exp. Med. 189 (1999) 1961-1972
87. Linington C., Lassmann H., Morgan B.P., and Compston D.A. Immunohistochemical localisation of terminal complement component C9 in experimental allergic encephalomyelitis. Acta Neuropathol. (Berl.) 79 (1989) 78-85
88. Lock K., Zhang J., Lu J., Lee S.H., and Crocker P.R. Expression of CD33-related siglecs on human mononuclear phagocytes, monocyte-derived dendritic cells and plasmacytoid dendritic cells. Immunobiology 209 (2004) 199-207
89. Lotze M.T., and Tracey K.J. High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 5 (2005) 331-342
90. Lu J., Teh C., Kishore U., and Reid K.B. Collectins and ficolins: Sugar pattern recognition molecules of the mammalian innate immune system. Biochim. Biophys. Acta 1572 (2002) 387-400
91. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M., and Lassmann H. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Ann. Neurol. 47 (2000) 707-717
92. Ma Y., Li J., Chiu I., Wang Y., Sloane J.A., Lu J., Kosaras B., Sidman R.L., Volpe J.J., and Vartanian T. Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis. J. Cell Biol. 175 (2006) 209-215
93. Magnus T., Chan A., Grauer O., Toyka K.V., and Gold R. Microglial phagocytosis of apoptotic inflammatory T cells leads to down regulation of microglial immune activation. J. Immunol. 167 (2001) 5004-5010
94. Marin-Teva J.L., Dusart I., Colin C., Gervais A., van Rooijen N., and Mallat M. Microglia promote the death of developing Purkinje cells. Neuron 41 (2004) 535-547
95. Martino G., Furlan R., Comi G., and Adorini L. The ependymal route to the CNS: An emerging gene-therapy approach for MS. Trends Immunol. 22 (2001) 483-490
96. Masada T., Xi G., Hua Y., and Keep R.F. The effects of thrombin preconditioning on focal cerebral ischemia in rats. Brain Res. 867 (2000) 173-179
97. Matzinger P. Friendly and dangerous signals: Is the tissue in control?. Nat. Immunol. 8 (2007) 11-13
98. McGeer P.L., and McGeer E.G. Innate immunity, local inflammation, and degenerative disease. Sci. Aging Knowledge Environ. 2002 (2002) re3
99. McGeer P.L., Akiyama H., Itagaki S., and McGeer E.G. Activation of the classical complement pathway in brain tissue of Alzheimer patients. Neurosci. Lett. 107 (1989) 341-346
100. McMenamin P.G. Distribution and phenotype of dendritic cells and resident tissue macrophages in the dura mater, leptomeninges, and choroid plexus of the rat brain as demonstrated in wholemount preparations. J. Comp. Neurol. 405 (1999) 553-562
101. Mead R.J., Singhrao S.K., Neal J.W., Lassmann H., and Morgan B.P. The membrane attack complex of complement causes severe demyelination associated with acute axonal injury. J. Immunol. 168 (2002) 458-465
102. Mead R.J., Neal J.W., Griffiths M.R., Linington C., Botto M., Lassmann H., and Morgan B.P. Deficiency of the complement regulator CD59a enhances disease severity, demyelination and axonal injury in murine acute experimental allergic encephalomyelitis. Lab. Invest. 84 (2004) 21-28
103. Medana I., Li Z., Flugel A., Tschopp J., Wekerle H., and Neumann H. Fas ligand (CD95L) protects neurons against perforin-mediated T lymphocyte cytotoxicity. J. Immunol. 167 (2001) 674-681
104. Medzhitov R., and Janeway Jr. C.A. Decoding the patterns of self and nonself by the innate immune system. Science 296 (2002) 298-300
105. Meri S., and Pangburn M.K. Discrimination between activators and nonactivators of the alternative pathway of complement: Regulation via a sialic acid/polyanion binding site on factor H. Proc. Natl. Acad. Sci. USA 87 (1990) 3982-3986
106. Minghetti L. Role of inflammation in neurodegenerative diseases. Curr. Opin. Neurol. 18 (2005) 315-321
107. Mollnes T.E., and Harboe M. Immunohistochemical detection of the membrane and fluid-phase terminal complement complexes C5b-9(m) and SC5b-9. Consequences for interpretation and terminology. Scand. J. Immunol. 26 (1987) 381-386
108. Morgan B.P., and Meri S. Membrane proteins that protect against complement lysis. Springer Semin. Immunopathol. 15 (1994) 369-396
109. Murata T., Ohnishi H., Okazawa H., Murata Y., Kusakari S., Hayashi Y., Miyashita M., Itoh H., Oldenborg P.A., Furuya N., and Matozaki T. CD47 promotes neuronal development through Src- and FRG/Vav2-mediated activation of Rac and Cdc42. J. Neurosci. 26 (2006) 12397-12407
110. Neumann H. Control of glial immune function by neurons. Glia 36 (2001) 191-199
111. Nguyen M.D., Julien J.P., and Rivest S. Innate immunity: The missing link in neuroprotection and neurodegeneration?. Nat. Rev. Neurosci. 3 (2002) 216-227
112. Oldenborg P.A., Gresham H.D., and Lindberg F.P. CD47-signal regulatory protein alpha (SIRPalpha) regulates Fcgamma and complement receptor-mediated phagocytosis. J. Exp. Med. 193 (2001) 855-862
113. Pachter J.S., de Vries H.E., and Fabry Z. The blood-brain barrier and its role in immune privilege in the central nervous system. J. Neuropathol. Exp. Neurol. 62 (2003) 593-604
114. Pasinetti G.M., Johnson S.A., Oda T., Rozovsky I., and Finch C.E. Clusterin (SGP-2): A multifunctional glycoprotein with regional expression in astrocytes and neurons of the adult rat brain. J. Comp. Neurol. 339 (1994) 387-400
115. Pender M.P., Nguyen K.B., McCombe P.A., and Kerr J.F. Apoptosis in the nervous system in experimental allergic encephalomyelitis. J. Neurol. Sci. 104 (1991) 81-87
116. Pindon A., Hantai D., Jandrot-Perrus M., and Festoff B.W. Novel expression and localization of active thrombomodulin on the surface of mouse brain astrocytes. Glia 19 (1997) 259-268
117. Prinz M., Garbe F., Schmidt H., Mildner A., Gutcher I., Wolter K., Piesche M., Schroers R., Weiss E., Kirschning C.J., Rochford C.D., Bruck W., et al. Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J. Clin. Invest. 116 (2006) 456-464
118. Rahpeymai Y., Hietala M.A., Wilhelmsson U., Fotheringham A., Davies I., Nilsson A.K., Zwirner J., Wetsel R.A., Gerard C., Pekny M., and Pekna M. Complement: A novel factor in basal and ischemia-induced neurogenesis. EMBO J. 25 (2006) 1364-1374
119. Raine C.S., Bonetti B., and Cannella B. Multiple sclerosis: Expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque. Rev. Neurol. (Paris) 154 (1998) 577-585
120. Reinhold M.I., Lindberg F.P., Plas D., Reynolds S., Peters M.G., and Brown E.J. In vivo expression of alternatively spliced forms of integrin-associated protein (CD47). J. Cell Sci. 108 Pt. 11 (1995) 3419-3425
121. Rogers J., Strohmeyer R., Kovelowski C.J., and Li R. Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide. Glia 40 (2002) 260-269
122. Roth J., Vogl T., Sorg C., and Sunderkotter C. Phagocyte-specific S100 proteins: A novel group of proinflammatory molecules. Trends Immunol. 24 (2003) 155-158
123. Rus H., Cudrici C., David S., and Niculescu F. The complement system in central nervous system diseases. Autoimmunity 39 (2006) 395-402
124. Savill J., Dransfield I., Gregory C., and Haslett C. A blast from the past: Clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2 (2002) 965-975
125. Schwartz M., Moalem G., Leibowitz-Amit R., and Cohen I.R. Innate and adaptive immune responses can be beneficial for CNS repair. Trends Neurosci. 22 (1999) 295-299
126. Scolding N., and Franklin R. Axon loss in multiple sclerosis. Lancet 352 (1998) 340-341
127. Seiffert M., Brossart P., Cant C., Cella M., Colonna M., Brugger W., Kanz L., Ullrich A., and Buhring H.J. Signal-regulatory protein alpha (SIRPalpha) but not SIRPbeta is involved in T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD34(+)CD38(-) hematopoietic cells. Blood 97 (2001) 2741-2749
128. Serafini B., Columba-Cabezas S., Di Rosa F., and Aloisi F. Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis. Am. J. Pathol. 157 (2000) 1991-2002
129. Sergent-Tanguy S., Veziers J., Bonnamain V., Boudin H., Neveu I., and Naveilhan P. Cell surface antigens on rat neural progenitors and characterization of the CD3(+)/CD3(-) cell populations. Differentiation 74 (2006) 530-541
130. Setzu A., Lathia J.D., Zhao C., Wells K., Rao M.S., Ffrench-Constant C., and Franklin R.J. Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells. Glia 54 (2006) 297-303
131. Shikamoto Y., and Morita T. Expression of factor X in both the rat brain and cells of the central nervous system. FEBS Lett. 463 (1999) 387-389
132. Simard A.R., Soulet D., Gowing G., Julien J.P., and Rivest S. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49 (2006) 489-502
133. Singhrao S.K., Neal J.W., Gasque P., Morgan B.P., and Newman G.R. Role of complement in the aetiology of Pick's disease?. J. Neuropathol. Exp. Neurol. 55 5 (1996) 578-593
134. Singhrao S.K., Neal J.W., Morgan B.P., and Gasque P. Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease. Exp. Neurol. 159 (1999) 362-376
135. Singhrao S.K., Neal J.W., Rushmere N.K., Morgan B.P., and Gasque P. Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis. Am. J. Pathol. 157 (2000) 905-918
136. Speth C., Dierich M.P., and Gasque P. Neuroinvasion by pathogens: A key role of the complement system. Mol. Immunol. 38 (2002) 669-679
137. Striggow F., Riek M., Breder J., Henrich-Noack P., Reymann K.G., and Reiser G. The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations. Proc. Natl. Acad. Sci. USA 97 (2000) 2264-2269
138. Stuart L.M., and Ezekowitz R.A. Phagocytosis: Elegant complexity. Immunity 22 (2005) 539-550
139. Sugita Y., Becerra S.P., Chader G.J., and Schwartz J.P. Pigment epithelium-derived factor (PEDF) has direct effects on the metabolism and proliferation of microglia and indirect effects on astrocytes. J. Neurosci. Res. 49 (1997) 710-718
140. Tahara K., Kim H.D., Jin J.J., Maxwell J.A., Li L., and Fukuchi K. Role of toll-like receptor signalling in Abeta uptake and clearance. Brain 129 (2006) 3006-3019
141. Tenner A.J. Membrane receptors for soluble defense collagens. Curr. Opin. Immunol. 11 (1999) 34-41
142. Tenner A.J. Complement in Alzheimer's disease: Opportunities for modulating protective and pathogenic events. Neurobiol. Aging 22 (2001) 849-861
143. Ubl J.J., Sergeeva M., and Reiser G. Desensitisation of protease-activated receptor-1 (PAR-1) in rat astrocytes: Evidence for a novel mechanism for terminating Ca2+ signalling evoked by the tethered ligand. J. Physiol. 525 Pt. 2 (2000) 319-330
144. Van Beek J., Bernaudin M., Petit E., Gasque P., Nouvelot A., MacKenzie E.T., and Fontaine M. Expression of receptors for complement anaphylatoxins C3a and C5a following permanent focal cerebral ischemia in the mouse. Exp. Neurol. 161 (2000) 373-382
145. van Beek J., Nicole O., Ali C., Ischenko A., MacKenzie E.T., Buisson A., and Fontaine M. Complement anaphylatoxin C3a is selectively protective against NMDA-induced neuronal cell death. Neuroreport 12 (2001) 289-293
146. van Beek J., van Meurs M., t Hart B.A., Brok H.P., Neal J.W., Chatagner A., Harris C.L., Omidvar N., Morgan B.P., Laman J.D., and Gasque P. Decay-accelerating factor (CD55) is expressed by neurons in response to chronic but not acute autoimmune central nervous system inflammation associated with complement activation. J. Immunol. 174 (2005) 2353-2365
147. Vaughan P.J., Pike C.J., Cotman C.W., and Cunningham D.D. Thrombin receptor activation protects neurons and astrocytes from cell death produced by environmental insults. J. Neurosci. 15 (1995) 5389-5401
148. Vernon-Wilson E.F., Kee W.J., Willis A.C., Barclay A.N., Simmons D.L., and Brown M.H. CD47 is a ligand for rat macrophage membrane signal regulatory protein SIRP (OX41) and human SIRPalpha 1. Eur. J. Immunol. 30 (2000) 2130-2137
149. Vivien D., and Buisson A. Serine protease inhibitors: Novel therapeutic targets for stroke?. J. Cereb. Blood Flow Metab. 20 (2000) 755-764
150. Wagner S., Lynch N.J., Walter W., Schwaeble W.J., and Loos M. Differential expression of the murine mannose-binding lectins A and C in lymphoid and nonlymphoid organs and tissues. J. Immunol. 170 (2003) 1462-1465
151. Walker D.G., Yasuhara O., Patston P.A., McGeer E.G., and McGeer P.L. Complement C1 inhibitor is produced by brain tissue and is cleaved in Alzheimer disease. Brain Res. 675 (1995) 75-82
152. Walport M.J. Complement. First of two parts. N. Engl. J. Med. 344 (2001) 1058-1066
153. Wang H., and Reiser G. Thrombin signaling in the brain: The role of protease-activated receptors. Biol. Chem. 384 (2003) 193-202
154. Weinstein J.R., Gold S.J., Cunningham D.D., and Gall C.M. Cellular localization of thrombin receptor mRNA in rat brain: Expression by mesencephalic dopaminergic neurons and codistribution with prothrombin mRNA. J. Neurosci. 15 (1995) 2906-2919
155. Wright G.J., Jones M., Puklavec M.J., Brown M.H., and Barclay A.N. The unusual distribution of the neuronal/lymphoid cell surface CD200 (OX2) glycoprotein is conserved in humans. Immunology 102 (2001) 173-179
156. Wyss-Coray T., and Mucke L. Inflammation in neurodegenerative disease-A double-edged sword. Neuron 35 (2002) 419-432
157. Xi G., Reiser G., and Keep R.F. The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: Deleterious or protective?. J. Neurochem. 84 (2003) 3-9
158. Yasuhara O., Aimi Y., McGeer E.G., and McGeer P.L. Expression of the complement membrane attack complex and its inhibitors in Pick disease brain. Brain Res. 652 (1994) 346-349
159. Yepes M., Sandkvist M., Wong M.K., Coleman T.A., Smith E., Cohan S.L., and Lawrence D.A. Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis. Blood 96 (2000) 569-576
160. Zhang K.Z., Junnikkala S., Erlander M.G., Guo H., Westberg J.A., Meri S., and Andersson L.C. Up-regulated expression of decay-accelerating factor (CD55) confers increased complement resistance to sprouting neural cells. Eur. J. Immunol. 28 (1998) 1189-1196
161. Zhang W., Wang T., Pei Z., Miller D.S., Wu X., Block M.L., Wilson B., Zhang W., Zhou Y., Hong J.S., and Zhang J. Aggregated alpha-synuclein activates microglia: A process leading to disease progression in Parkinson's disease. FASEB J. 19 (2005) 533-542
162. Zipp F., Krammer P.H., and Weller M. Immune (dys) regulation in multiple sclerosis: Role of the CD95-CD95 ligand system. Immunol. Today 20 (1999) 550-554